Xue X P, Tong X, Sun M J, Wang P C, Liu A H
Department of Neurosurgery, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing100070, China.
Department of Neurosurgery, Hainan Hospital, Affiliated to Hainan Medical University, Haikou570311, China.
Zhonghua Wai Ke Za Zhi. 2024 Dec 1;62(12):1113-1119. doi: 10.3760/cma.j.cn112139-20240613-00293.
To investigate the midterm and long-term efficacy of flow-diverter device in treating intracranial aneurysms (IAs) and analyze its clinical outcomes in anterior circulation aneurysms and posterior circulation aneurysms. This is a retrospective case series study. The data of 566 intracranial aneurysm patients (681 aneurysms) treated with the flow-diverter device at Department of Neurosurgery, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University from January 2018 to January 2021 were retrospectively analyzed. There were 205 males and 361 females, with an age ((IQR)) of 55 (14) years (range:18 to 77 years). Twelve patients (12 aneurysms) had ruptured aneurysms before surgery, and 75 patients (172 aneurysms) had multiple aneurysms. Preoperative modified Rankin scale (mRS) >2 points in 16 patients.There were 444 patients (552 aneurysms) in the anterior circulation group and 122 patients (129 aneurysms) in the posterior circulation group. Postoperative follow-up was conducted via outpatient visits or telephone calls at 3 to 12 months after the procedure. Baseline aneurysm parameters, surgical information, and imaging and clinical outcomes were collected. Univariate and multivariate Logistic regression analyses were used to identify independent factors associated with long-term incomplete aneurysm occlusion. Intraoperative use of flow diverter-assisted coil embolization was performed in 221 patients (226 aneurysms), and balloon assistance was used in 20 patients (22 aneurysms).The intraoperative rupture rate was 0.5% (3/566), and the intraoperative thrombosis rate was 0.7% (4/566). The in-hospital mortality rate was 1.2% (7/566). Postoperative complications included subarachnoid hemorrhage in 5 patients (0.9%), intracerebral hemorrhage in 2 patients (0.4%), ischemic stroke in 19 patients (3.6%), and transient ischemic attack in 16 patients (3.0%). Imaging follow-up was available for 447 patients (548 aneurysms) with a follow-up duration of (16.7±6.7) months (range:3 to 45 months). Incomplete aneurysm occlusion occurred in 79 patients (95 aneurysms), accounting for 17.3% (95/548). Parent artery stenosis was observed in 63 patients (72 aneurysms), accounting for 13.1% (72/548). Clinical follow-up was available for 530 patients (644 aneurysms) with a follow-up duration of (29.4±11.3) months (range:3 to 54 months). One case of mRS score >2 points was observed in 18 patients, accounting for 3.4% (18/530). Among them, the rate of incomplete occlusion in the anterior and posterior circulation group was 16.9% (76/450) and 19.4% (19/98), respectively, and the rate of parent artery stenosis was 10.9% (49/450) and 23.5% (23/98), respectively; the rate of mRS score>2 points was 2.4% (10/415) and 7.0% (8/115), respectively. Univariate and multivariate Logistic regression analysis showed that aneurysm neck size (=0.075,=1.08, =0.028) and coil use (=-1.070, =0.034, =0.001) were independent factors influencing long-term aneurysm occlusion. The flow-diverter device demonstrates good safety and efficacy in the midterm and long-term treatment of overall IAs. However, further research is needed to focus on the midterm and long-term treatment outcomes of aneurysms with relatively wide neck and posterior circulation aneurysms.
探讨血流导向装置治疗颅内动脉瘤(IA)的中期和长期疗效,并分析其在前循环动脉瘤和后循环动脉瘤中的临床结果。这是一项回顾性病例系列研究。回顾性分析了2018年1月至2021年1月在首都医科大学附属北京天坛医院北京神经外科研究所神经外科接受血流导向装置治疗的566例颅内动脉瘤患者(681个动脉瘤)的数据。其中男性205例,女性361例,年龄(四分位间距)为55(14)岁(范围:18至77岁)。12例患者(12个动脉瘤)术前有动脉瘤破裂,75例患者(172个动脉瘤)有多发动脉瘤。术前改良Rankin量表(mRS)>2分的患者有16例。前循环组有444例患者(552个动脉瘤),后循环组有122例患者(129个动脉瘤)。术后通过门诊或电话随访3至12个月。收集基线动脉瘤参数、手术信息以及影像学和临床结果。采用单因素和多因素Logistic回归分析确定与长期动脉瘤不完全闭塞相关的独立因素。221例患者(226个动脉瘤)术中使用了血流导向辅助弹簧圈栓塞,20例患者(22个动脉瘤)使用了球囊辅助。术中破裂率为0.5%(3/566),术中血栓形成率为0.7%(4/5)。住院死亡率为1.2%(7/566)。术后并发症包括5例患者(0.9%)发生蛛网膜下腔出血,2例患者(0.4%)发生脑出血,19例患者(3.6%)发生缺血性卒中,16例患者(3.0%)发生短暂性脑缺血发作。447例患者(548个动脉瘤)有影像学随访,随访时间为(16.7±6.7)个月(范围:3至45个月)。79例患者(95个动脉瘤)出现动脉瘤不完全闭塞,占17.3%(95/548)。63例患者(72个动脉瘤)观察到载瘤动脉狭窄,占13.1%(72/548)。530例患者(64个动脉瘤)有临床随访,随访时间为(29.4±11.3)个月(范围:3至54个月)。18例患者中观察到1例mRS评分>2分,占3.4%(18/530)。其中,前循环组和后循环组的不完全闭塞率分别为16.9%(76/450)和19.4%(19/98),载瘤动脉狭窄率分别为10.9%(49/450)和23.5%(23/98);mRS评分>2分的发生率分别为2.4%(10/415)和7.0%(8/115)。单因素和多因素Logistic回归分析显示,动脉瘤颈大小(=0.075,=1.08,=0.028)和弹簧圈使用(=-1.070,=0.034,=0.001)是影响长期动脉瘤闭塞的独立因素。血流导向装置在IA的中期和长期治疗中显示出良好的安全性和疗效。然而,需要进一步研究关注颈相对较宽的动脉瘤和后循环动脉瘤的中期和长期治疗结果。